Q4 2024 Agilent Technologies Inc Earnings Call Transcript
Key Points
- Agilent Technologies Inc (A) reported a sequential improvement in revenue growth, with a book-to-bill ratio greater than one, indicating a steady market recovery.
- The company gained market share in all geographies, demonstrating strong customer trust even in a challenging CapEx environment.
- Agilent Technologies Inc (A) introduced a new market-focused organizational structure to enhance customer-centricity and accelerate performance.
- The Agilent CrossLab Group achieved double-digit growth in its contracts business, highlighting strong customer relationships and service offerings.
- The company successfully closed the acquisition of BIOVECTRA, expanding its portfolio of CDMO services and enhancing capabilities in rapidly growing therapeutic modalities.
- Agilent Technologies Inc (A) experienced a decline in core revenue growth, with a reported growth of only 0.8% for the fourth quarter.
- The life sciences and applied markets group saw a 1% decline in revenue due to constrained customer CapEx spending.
- The diagnostics and genomics group posted a 3% decline in revenue, with expected softness in NASD and cell analysis instruments.
- The environmental and forensics market declined by 6%, with the US market particularly affected by timing of orders.
- The company anticipates a slower market growth rate for fiscal year 2025, with a conservative approach to revenue associated with China stimulus.
Good afternoon. My name is Rob, and I will be your conference operator today. At this time, I would like to welcome everyone to the Agilent Technologies, Inc. fourth-quarter 2024 earnings conference call. (Operator Instructions)
Parmeet Ahuja, you may begin your conference.
Thank you, and welcome, everyone, to Agilent's conference call for the fourth quarter of fiscal year 2024. I'm sure you have seen our press release earlier today regarding our new market-focused organizational structure, which we will talk about in more detail. These changes have no impact on our company's consolidated financial statements. All financial metrics and guidance during this call will be shared under our historical structure. We will provide recast historical segment information to reflect these changes ahead of our upcoming Investor Day.
Now, on to our quarterly results. With me are Padraig McDonnell, Agilent's President and CEO; and Bob McMahon, Agilent's Senior Vice President and
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |